Grants FY18-19

NMRC

• “Optimising the Assessment of Quality of Life in Glaucoma Using Item Bank and Computer Adaptive Testing Systems”.
  Dr Eva Harper; S$748,525.00

• “Application and Evaluation of an Artificial Intelligence Deep Learning System to Detect Referable and Sight-threatening Retinal Diseases in the Singapore Integrated Diabetic Retinopathy Screening Programme (SiDRP): Screening Performance and Cost-effectiveness Analysis”.
  Dr Daniel Ting; S$1,138,261.00

A*Star/ Duke-NUS/ MOH/ Others

• “Preclinical Evaluation of Antimicrobial Dressings in Psuedomonas Aeruginosa Infected Burns Wounds”.
  A/Prof Lakshminarayanan Rajamani; S$104,000.00

• “Light and outdoor patterns for the prevention of myopia (Sunflower Project)”.
  Prof Saw Seang Mei; S$1,465,833.33

• “Non-leachable Antimicrobial Electrospun Nanofibre Mats for the Treatment of Topical Infections”.
  A/Prof Lakshminarayanan Rajamani; S$208,333.00

SingHealth

• “Development of a Novel Descemet Membrane Endothelial Keratoplasty Surgical Device”.
  Dr Marcus Ang; S$100,000.00

• “Evaluation of safety and device retention of modified keratoprosthesis in animal model”.
  Dr Andri Kartasasmita Riau; S$150,000.00

• “Clinical and Cost-effectiveness Analysis on Artificial Intelligence using Deep Learning System for Diabetic Retinopathy Screening”.
  Dr Daniel Ting; S$128,000.00

• “Functional characterization of complement pathway inhibitors complement factor H (CFH) and complement factor I (CFI) in a human in vitro model of complement activation in age-related macular degeneration (AMD)”.
  Dr Fabio Michelet; S$49,510.00

• “Evaluating atorvastatin loaded solid lipid nanoparticulate formulation for its purported use in the management of Age Related Macular Degeneration using a suitable animal model”.
  Dr Amutha Barathi Veluchamy; S$73,823.53

• “Investigating the In vivo Safety and Efficacy of Cell-selective Pore-forming Peptides”.
  A/Prof Lakshminarayanan Rajamani; S$149,563.00
  

• “Investigating Signal Transduction Pathways in Conjunctival Fibrosis: Therapeutic Potential of Novel Selective Inhibition”.
  Dr Ong Hon Shing; S$50,000.00